About | Free Trial

Last Update

2016-04-19T00:00:00.000Z

This profile was last updated on . .

Is this you? Claim your profile.

Wrong Charles Saldarini?

Mr. Charles Saldarini T.

Co-Founder and Chief Operating Officer

RELOVATE

HQ Phone:

RELOVATE

200 Valley Road, Suite 108

Mount Arlington, New Jersey 07856

United States

Find other employees at this company (10)

Background Information

Employment History

Managing Partner
Votetocracy

Vice Chairman and Chief Executive Officer
Inserve Inc

Chief Executive Officer
Sentrx

Affiliations

Board of Advisors
Syracuse University Board of Visitors

Venture Advisor
Mid Atlantic Fund

Member Board of Directors
TrialScope Inc

Member Board of Directors
Rapid Pathogen Screening , Inc.

Board Member
Syracuse University

Head of Global Business Development
Octagon Research Solutions Inc

Founding Board Member
CharityNavigator.com

Board Member
Cadient Group

Board Member, Independent Director
Informed Medical Communications Inc

Education

BA
Political Science and Communications Management
Syracuse University

Web References (171 Total References)


Charles T. ...

midatlanticfund.com [cached]

Charles T. Saldarini

Venture Advisor
...
Charles T. Saldarini
Mr. Charles T. Saldarini is currently the Co-Founder of Relovate, a private marketplace for online trip planning and booking, launching in Spring, 2016.
Related Internet start-up experience includes VoteTocracy, an award-winning political engagement website enabling citizens to vote on any bill presently pending in the U.S. Congress. Furthermore, he was a founding Board member at CharityNavigator.com, the nation's largest and most-utilized evaluator of charities.
Presently, Mr. Saldarini serves on two Executive Boards in life-sciences, including TrialScope, a Software as a Service (SaaS) business, providing a best-in-class trial disclosure information solution and also on RPS, a rapid pathogen screening company providing innovative point-of-care diagnostic solutions. He is an expert in biopharmaceutical services, having held multiple executive leadership roles, notably, Head of Global Business Development for Octagon Clinical Research Solutions (sold to Accenture), CEO and Vice Chairman of Sentrx (sold to Merck) and CEO and Vice Chairman of PDI (IPO, 1998).
Mr. Saldarini serves on the Syracuse University Board of Visitors as well as his local Board of Education, and until recently was actively competing in several triathlons each year.


Board of Directors

www.rpsdetectors.com [cached]

Back row (standing - left to right): Charles Saldarini, Stephen La Neve, Caroline Popper

...
Charles T. Saldarini Director
Charles Saldarini is an expert in biopharmaceutical services and a proven leader across all phases of growth and turnaround. He is currently the Founder and CEO of The Charles T. Saldarini Group, where he provides strategic assessments for private equity investment, commercial product development, and growth opportunities for life science companies. Most recently, Saldarini served as head of Global Business Development for Octagon Clinical Research Solutions and as a member of the deal team that led the organization's sale to Accenture. Previously, he was CEO and Vice Chairman of Sentrx, where he successfully led a complete turnaround resulting in measurably higher quality, improved competitive position, and sustained profitability. Sentrx was recently acquired by TeleRx. Saldarini also led PDI, Inc., as CEO and Vice Chairman from its inception through peak service revenues of $365 million. In addition to RPS, Saldarini also serves on the Syracuse University Board of Visitors and his local Board of Education. Saldarini earned his BA in Political Science and Communications Management from Syracuse University.


Board of Directors

www.rpsdetectors.com [cached]

Back row (standing - left to right):Charles Saldarini,Stephen La Neve, Caroline Popper

...
Charles T. Saldarini Director
Charles Saldarini is an expert in biopharmaceutical services and a proven leader across all phases of growth and turnaround. He is currently the Founder and CEO of The Charles T. Saldarini Group, where he provides strategic assessments for private equity investment, commercial product development, and growth opportunities for life science companies. Most recently, Saldarini served as head of Global Business Development for Octagon Clinical Research Solutions and as a member of the deal team that led the organization's sale to Accenture. Previously, he was CEO and Vice Chairman of Sentrx, where he successfully led a complete turnaround resulting in measurably higher quality, improved competitive position, and sustained profitability. Sentrx was recently acquired by TeleRx. Saldarini also led PDI, Inc., as CEO and Vice Chairman from its inception through peak service revenues of $365 million. In addition to RPS, Saldarini also serves on the Syracuse University Board of Visitors and his local Board of Education. Saldarini earned his BA in Political Science and Communications Management from Syracuse University.


Electronic Data Capture Vendor Integrated Clinical Systems Inc

edcmarket.appspot.com [cached]

Chuck Saldarini, CEO of Sentrx Safety Solutions, focuses on the use of the "Cloud" to turn fixed costs into variable costs: "It's not yet 2012, but for budget planning it's already here.


Board of Directors | TrialScope

www.trialscopeinc.com [cached]

Charles Saldarini Managing Partner, VoteTocracy Read More Read Less

Chuck is currently managing partner of VoteTocracy and a member of the Board of Directors at Rapid Pathogen Screening, Inc. Chuck is also the Founder and CEO of The Charles T. Saldarini Group, where he provides strategic assessments for private equity investment, commercial product development, and growth opportunities for life science companies. Most recently, Chuck served as head of Global Business Development for Octagon Clinical Research Solutions and as a member of the deal team that led the organization's sale to Accenture.
Previously, he was CEO and Vice Chairman of Sentrx, where he successfully led a complete turnaround resulting in measurably higher quality, improved competitive position, and sustained profitability. Sentrx was recently acquired by TeleRx. Chuck also led PDI, Inc., as CEO and Vice Chairman from its inception through peak service revenues of $365 million. In addition to RPS, Chuck also serves on the Syracuse University Board of Visitors and his local Board of Education. He earned his BA in Political Science and Communications Management from Syracuse University.

Similar Profiles

Other People with this Name

Other people with the name Saldarini

Candace Saldarini
ODH Inc

Joe-Anne Saldarini
LinkedIn

Ross Saldarini
Mountain Khakis

Robert Saldarini
Bergen Community College

Ronald Saldarini

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory